LabVantage

From next-generation biologics to smarter capsule technology and cleaner supplier communication, this ebook brings together 4 insights at where formulation science is headed and what it takes to get complex therapies safely from lab to patient. Inside, readers will find a look into the stability challenges of emerging biologics such as antibody-drug conjugates and bispecifics, including real-world case studies on taming viscosity and solubility at high concentrations. The industry's accelerating shift from IV to subcutaneous delivery is discussed, unpacking the regulatory approvals, patient-outcome data, and market forces turning at-home biologic dosing into standard practice. On the drug-delivery-innovation side, a feature on a novel capsule-in-capsule platform shows how liquid and solid actives can be combined in a single dose to cut pill burden without sacrificing performance. Rounding this eBook out, an IPEC-Americas explainer shows how the Excipient Information Package can replace slow, inconsistent supplier questionnaires with a standardized format that speeds qualification from months to days.

Pharmaceutical R&D teams must accelerate innovation while managing complex scientific data, disconnected research systems, and increasing regulatory expectations. This white paper explores how integrated lab informatics can create a connected digital foundation for research, linking data, workflows, instruments, and teams across the R&D lifecycle. Discover how modern informatics can strengthen collaboration and reproducibility, automate routine processes, and enable more confident, data-driven decisions in drug discovery and development.

Pharmaceutical manufacturing laboratories must maintain reliable data, controlled processes, and regulatory readiness while supporting efficient quality operations. This white paper examines how a purpose-built, pre-validated LIMS can replace manual and disconnected workflows with integrated sample management, instrument connectivity, secure audit trails, and embedded quality-management capabilities. Learn how a modern LIMS can help improve data integrity, streamline laboratory operations, support compliant batch release, and protect product quality.

WHY A PURPOSE-BUILT LIMS? The Data Management Challenge A successful lab is more than a scientific hub. In today’s age, it’s a digital data enterprise. But should that platform be one-size-fits-all across industries? A pharma lab needs regulatory documentation, while a diagnostics lab requires advanced tracking of biospecimens. Traditionally, each would begin with the same basic building blocks: a Laboratory Information Management System (LIMS) with standalone point solutions such as an Electronic Laboratory Notebook (ELN) or a Laboratory Execution System (LES) daisy-chained together to approximate an end-to-end solution. Then, through a complex à-la-carte development and validation process, each of these labs would customize their platform in response to their divergent needs. Until now.

LabVantage is advancing software as a service (SaaS) for the laboratory information management system (LIMS) market to provide laboratories with reduced costs and pre-validated solutions that facilitate scalability and faster speed-to-market for pharmaceuticals

This piece of content details how LabVantage Pharma LIMS serves pharmaceutical manufacturers with built-in compliance, speed, and quality assurance. It describes a pre-validated, purpose-built platform that supports FDA 21 CFR Part 11, EudraLex Annex 11, and GxP standards. The system enables rapid deployment (go-live in ~90 days), automated workflows, instant Certificates of Analysis, and robust security. Labs can simplify operations, strengthen compliance, and accelerate batch release while safeguarding product quality.

The following white paper explores how next-generation lab informatics solutions can transform the life science industry by addressing challenges like data silos, compliance risks, and manual workflows. The white paper further highlights the strategic value of cloud-based platforms integrating LIMS, ELN, and AI-driven analytics to accelerate breakthroughs, foster and enhance collaboration, and ensure data integrity. Real-world implementations show up to 40% faster data processing and improved decision-making. The paper concludes that digital, connected, and intelligent lab ecosystems are key to achieving smarter, faster, and more efficient pharma innovation.

AI-powered prognostics used in histopathology can reveal complex patterns in tissue and cells that exceed human vision capabilities. We present how the incorporation of these models into laboratory workflows creates more objective, reproducible, and scalable processes. This affords greater diagnostic accuracy, faster turnaround times, and patient care that best fits their needs. By handling variability and subjectivity in traditional methods, this approach supports more confident prognoses and better clinical outcomes.

Drive growth by establishing integrated, AI-fueled lab systems and a data-driven corporate culture that’s ready and resilient, no matter what business challenges emerge tomorrow. Evolving to a Lab of the Future takes the right technologies, systems, and expert guidance.

As today’s labs continue to evolve, the software solutions that support them must too. Likewise, laboratory and organization leadership must be open to the advance-ments available to them from modern technologies. In this white paper, learn how a SaaS-based LIMS modernization program optimizes data management, fosters collaboration, and improves decision-making to stay at the forefront of scientific innovation.

The efficiencies and insights of artificial intelligence (AI), machine learning (ML), predictive analytics, and other emerging technologies offer abundant opportunities to laboratories. To help customers leverage digital transformation and prepare for the lab of the future, LabVantage Solutions has devised a five-step process for successfully implementing and profiting from AI in the lab.

The lab of the future is about the whole enterprise. It generates business value by using advanced digital tools and techniques to make contextualized, actionable scientific data available at the bench, in the executive boardroom, and wherever that data can help generate revenue, accelerate innovation, and drive meaningful business decisions. This paper will help you keep up—and even get ahead—in a future that’s rapidly approaching.

The term “digital transformation” attracts a lot of hype. No wonder: the modern gleam of digital and the big-picture promise of that word transformation are irresistible. So much of that hype is based on speculation and inflated claims, though. This paper is your answer. It provides a hype-free account of three transformational projects undertaken in three intensely competitive industries.

The efficiencies and insights of artificial intelligence (AI), machine learning (ML), predictive analytics, and other emerging technologies offer abundant opportunities to laboratories. To help customers leverage digital transformation and prepare for the lab of the future, LabVantage Solutions has devised a five-step process for successfully implementing and profiting from AI in the lab.

Jeroen De Haas, Senior Product Manager at LabVantage Solutions discusses how advanced analytics such as AI are moving into the lab, helping biopharmaceutical organizations draw far greater actionable insights from a broader array of data. Intelligent LIMS leveraging these advanced analytics are at the heart of a lab’s digital transformation.